William Cadden: Risk–Benefit Considerations in Atrial Fibrillation
William Cadden, Director of Medical Device Partnerships at Radcliffe Group, shared a post on LinkedIn:
“At ACC26, Dr Devi G Nair and Dr Vivek Reddy discussed the implications of the late-breaking CHAMPION-AF data, focusing on a central clinical question: how should we weigh stroke risk against bleeding reduction?
The data suggest a modest absolute increase in ischaemic stroke and systemic embolism with a device-based strategy, offset by a substantial reduction in clinically relevant bleeding.
Interpreting this balance is not straightforward and depends on how different endpoints are valued in practice.
A key part of the discussion explored whether all bleeding events should be considered equal, particularly when ‘clinically relevant non-major’ bleeding is included alongside more severe outcomes.
Similarly, the role of procedure-related complications within composite endpoints remains an important consideration when assessing overall benefit.
Ultimately, the conversation reinforces that this is not a one-size-fits-all decision.
The relative importance of stroke prevention versus bleeding avoidance will vary between patients, and careful selection remains essential when considering first-line left atrial appendage closure versus continued anticoagulation.
As longer-term follow-up becomes available, these trade-offs will become clearer and further inform clinical decision-making.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Apr 24, 2026, 06:58Zahra Ghasemi: The Human Reality of IVIG Access
-
Apr 24, 2026, 06:44Sandrine Meunier: Raising Awareness and Support for Hemophilia and Rare Bleeding Disorders
-
Apr 24, 2026, 06:25Octavio Marques Pontes-Neto: A Landmark Step in Stroke Prevention from The TRIDENT Trial Findings
-
Apr 24, 2026, 05:46Muhammad Alsabagh: Structured Clinical Algorithms for Pediatric and AYA Bone Marrow Failure Syndromes
-
Apr 23, 2026, 22:56Matt Simmonds: Having a Really Fabulous Time at the BSH 2026 Conference
-
Apr 23, 2026, 22:46Gloria Duah: Not All ‘O Negative’ Blood Is Safe for Every Patient
-
Apr 23, 2026, 22:46Luke McLaughlin: Is Haemophilia a Disability?
-
Apr 23, 2026, 22:44Sonia Wolf: On My Way Back From a Very Invigorating BSH
-
Apr 23, 2026, 22:43Maximo Agustin Schiavone: ‘The Lower the Better’ Is Not a Physiological Principle